Dietary exposure to food preservatives associated with higher cancer incidence
View as a Web Page
News Medical
 
  Breast Cancer Breast Cancer logo  
  The latest breast cancer news from News Medical  
 Low-dose megestrol strengthens hormone therapy in ER-positive breast cancerLow-dose megestrol strengthens hormone therapy in ER-positive breast cancer
 
Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving treatment adherence in the PIONEER trial.
 
 
 Dietary exposure to food preservatives associated with higher cancer incidenceDietary exposure to food preservatives associated with higher cancer incidence
 
Higher intake of food preservatives, widely used in industrially processed foods and beverages to extend shelf-life, is associated with a modestly increased risk of cancer, finds a study from France published by The BMJ today.
 
   Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative breast cancer
 
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy.
 
   How CDMOs Drive Higher ADC Manufacturing Yields in One StepHow CDMOs Drive Higher ADC Manufacturing Yields in One Step
 
Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.
 
 Targeting IDO1 for cancer: Novel degraders show promise in preclinical studies
 
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these escape mechanisms.
 
 
 Whole-genome sequencing improves PARP inhibitor treatment prediction
 
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
 
 
 AI trained on sleep data predicts future disease and mortality years in advance
 
AI trained on sleep data predicts future disease and mortality years in advanceThe SleepFM model reveals how sleep analysis can predict disease risk, offering insights into sleep's role as a vital health indicator for early intervention.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026